Gene Trio May Confer Radiation Resistance To Cancer Cells; Can a Molecular Dx Follow? | GenomeWeb

A team of researchers from industry and academia said they have identified a group of proteins whose expression level will help determine which cancer patients are best suited to radiotherapy or chemotherapy, eliminating intensive, harmful radiation treatment for patients whose tumors are resistant to the treatment.

The group's research is published in this week's issue of the Journal of Biochemistry.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.